S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54

GoHealth Stock Forecast, Price & News

-0.01 (-1.65%)
(As of 06/28/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1.14 million shs
Average Volume
3.23 million shs
Market Capitalization
$191.51 million
P/E Ratio
Dividend Yield
Price Target
30 days | 90 days | 365 days | Advanced Chart

Receive GOCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GoHealth and its competitors with MarketBeat's FREE daily newsletter.

GOCO Stock Forecast (MarketRank)

Overall MarketRank

2.14 out of 5 stars

Finance Sector

710th out of 1,394 stocks

Insurance Agents, Brokers, & Service Industry

13th out of 25 stocks

Analyst Opinion: 2.9Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -
GoHealth logo

About GoHealth (NASDAQ:GOCO)

GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareInternal; MedicareExternal; Individual and Family Plans (IFP) and OtherInternal; and IFP and OtherExternal. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. Its products include Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans; and IFP, dental plans, vision plans, and other ancillary plans to individuals. The company sells its products through carriers and online platform, as well as independent and external agencies. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois with additional offices in Charlotte, North Carolina, Lindon, Utah, Bratislava, Slovakia, and Kosice, Slovakia.

GOCO Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Insurance agents, brokers, & service
Current Symbol
Year Founded

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
9 Analysts


Net Income
$-189.36 million
Pretax Margin


Sales & Book Value

Annual Sales
$1.06 billion
Cash Flow
$1.99 per share
Book Value
$2.78 per share


Free Float
Market Cap
$191.51 million
Not Optionable

GoHealth Frequently Asked Questions

Should I buy or sell GoHealth stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GoHealth in the last year. There are currently 2 sell ratings, 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" GoHealth stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GOCO, but not buy additional shares or sell existing shares.
View analyst ratings for GoHealth
or view top-rated stocks.

What is GoHealth's stock price forecast for 2022?

9 Wall Street research analysts have issued 1-year target prices for GoHealth's stock. Their GOCO stock forecasts range from $1.50 to $5.50. On average, they anticipate GoHealth's share price to reach $3.04 in the next twelve months. This suggests a possible upside of 408.8% from the stock's current price.
View analysts' price targets for GoHealth
or view top-rated stocks among Wall Street analysts.

How has GoHealth's stock performed in 2022?

GoHealth's stock was trading at $3.79 at the beginning of the year. Since then, GOCO stock has decreased by 84.3% and is now trading at $0.5966.
View the best growth stocks for 2022 here

When is GoHealth's next earnings date?

GoHealth is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022.
View our earnings forecast for GoHealth

How were GoHealth's earnings last quarter?

GoHealth, Inc. (NASDAQ:GOCO) announced its earnings results on Tuesday, May, 10th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.09) by $0.03. The firm had revenue of $270.59 million for the quarter, compared to analyst estimates of $165.57 million. GoHealth had a positive trailing twelve-month return on equity of 10.28% and a negative net margin of 17.78%.
View GoHealth's earnings history

What guidance has GoHealth issued on next quarter's earnings?

GoHealth updated its FY 2022 earnings guidance on Tuesday, June, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $900.00M-$1.10 billion, compared to the consensus revenue estimate of $993.51 million.

Who are GoHealth's key executives?

GoHealth's management team includes the following people:
  • Mr. Brandon M. Cruz, Co-Founder & Non-Exec. Co-Chairman (Age 44, Pay $1.76M) (LinkedIn Profile)
  • Mr. Clinton P. Jones, Co-Founder & Exec. Co-Chairman (Age 44, Pay $930.77k) (LinkedIn Profile)
  • Mr. Brian P. Farley, Chief Legal Officer & Corp. Sec. (Age 52, Pay $590.43k)
  • Mr. Vijay Kumar Kotte, CEO & Director (Age 44)
  • Mr. Jason Schulz, Chief Financial Officer
  • Mr. Shane E. Cruz, Chief Operating Officer (Age 42) (LinkedIn Profile)
  • Mr. Cem Varon, Chief Technology Officer
  • Ms. Melissa Balsan, Chief Marketing Officer
  • Mr. Mark Monitello, Chief HR Officer
  • Mr. Ben Miller, Chief Growth Officer

What is Matthew Crummack's approval rating as GoHealth's CEO?

25 employees have rated GoHealth CEO Matthew Crummack on Glassdoor.com. Matthew Crummack has an approval rating of 90% among GoHealth's employees.

What other stocks do shareholders of GoHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GoHealth investors own include Tesla (TSLA), Alibaba Group (BABA), CVS Health (CVS), (HON), Moderna (MRNA), Raytheon Technologies (RTX), Walmart (WMT), Cisco Systems (CSCO), Intel (INTC) and Johnson & Johnson (JNJ).

When did GoHealth IPO?

(GOCO) raised $750 million in an initial public offering on Wednesday, July 15th 2020. The company issued 39,500,000 shares at $18.00-$20.00 per share. Goldman Sachs, BofA Securities and Morgan Stanley acted as the underwriters for the IPO and Barclays, Credit Suisse, Evercore ISI, RBC Capital Markets, William Blair, Cantor, SunTrust Robinson Humphrey and Loop Capital Markets were co-managers.

What is GoHealth's stock symbol?

GoHealth trades on the NASDAQ under the ticker symbol "GOCO."

Who are GoHealth's major shareholders?

GoHealth's stock is owned by a number of institutional and retail investors. Top institutional shareholders include First Trust Advisors LP (1.60%), Vanguard Group Inc. (1.45%), BlackRock Inc. (1.02%), Renaissance Technologies LLC (0.77%), State Street Corp (0.34%) and Healthcare of Ontario Pension Plan Trust Fund (0.34%). Company insiders that own GoHealth stock include Anita Pramoda, Brandon M Cruz, Clinton P Jones, Clinton P Jones, Nvx Holdings, Inc, Shane E Cruz and Travis J Matthiesen.
View institutional ownership trends for GoHealth

Which major investors are selling GoHealth stock?

GOCO stock was sold by a variety of institutional investors in the last quarter, including Glendon Capital Management LP, Vanguard Group Inc., Raymond James & Associates, Birch Grove Capital LP, Invesco Ltd., Daiwa Securities Group Inc., Assenagon Asset Management S.A., and Rothschild Investment Corp IL. Company insiders that have sold GoHealth company stock in the last two years include Shane E Cruz, and Travis J Matthiesen.
View insider buying and selling activity for GoHealth
or view top insider-selling stocks.

Which major investors are buying GoHealth stock?

GOCO stock was bought by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Renaissance Technologies LLC, Healthcare of Ontario Pension Plan Trust Fund, BlackRock Inc., Goldman Sachs Group Inc., Bank of America Corp DE, Oak Thistle LLC, and State Street Corp. Company insiders that have bought GoHealth stock in the last two years include Anita Pramoda, Brandon M Cruz, Clinton P Jones, and Nvx Holdings, Inc.
View insider buying and selling activity for GoHealth
or or view top insider-buying stocks.

How do I buy shares of GoHealth?

Shares of GOCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is GoHealth's stock price today?

One share of GOCO stock can currently be purchased for approximately $0.60.

How much money does GoHealth make?

GoHealth (NASDAQ:GOCO) has a market capitalization of $191.51 million and generates $1.06 billion in revenue each year. The company earns $-189.36 million in net income (profit) each year or ($1.770010) on an earnings per share basis.

How many employees does GoHealth have?

GoHealth employs 5,448 workers across the globe.

How can I contact GoHealth?

GoHealth's mailing address is 214 WEST HURON STREET, CHICAGO IL, 60654. The official website for GoHealth is www.gohealth.com. The company can be reached via phone at 312-386-8200 or via email at [email protected].

This page (NASDAQ:GOCO) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.